MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹3.66 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.66 Cr | -65.52 | |
| Mar2024 | ₹11 Cr | -30.98 | |
| Mar2023 | ₹15 Cr | 11.78 | |
| Mar2022 | ₹14 Cr | 89.48 | |
| Mar2021 | ₹7.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,017.1 Cr | -1.1% | 7.8% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -1.1% |
7.8% |
-16.2% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses